Guest
Guest
Apr 20, 2026
8:32 PM
|
Neoantigens are highly immunogenic but often patient-specific and costly to identify, limiting their scalability. In contrast, TAA-derived cryptic peptides have low self-tolerance and broader applicability across patients, offering a more universal vaccine strategy while maintaining immunogenic potential after optimization.
|